Research & Development



  他很想跳到雲瑯的戰車上去,把雲瑯活活的撕碎,卻驚奇的發現,雲瑯跑的比任何人都快,直到此時,何愁有才看清楚,別的戰車都是由兩匹挽馬拖拽的,只有雲瑯的戰車是四匹最強壯的戰馬拖拽的。   木筏最前邊只有雲瑯甦稚曹襄三人,曹襄輕輕的嘆口氣道︰“雖然我亞父做的沒錯,那時候我們活該被犧牲,可是,我的心還是有些隱隱發冷!”52avav我爱aⅴ在线观看   守候在門口的良姬趕緊把東方朔攙扶到店里埋怨道︰“就不能少喝一點酒嗎?監牢里不許我過夜,睡死過去可怎麼好。”亚洲人妻av伦理   東方朔那里忍耐的住,提著一個韭菜盒子的角就狠狠咬了一口……嘴巴已經被燙出燎泡了,他依舊不願意放棄美味的韭菜盒子。亚洲在线AV极品无码   右賢王麾下大當戶赫爾度回答道︰“是這樣的,這一次,就讓我們在這里把他們都埋葬掉吧。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo